Biomarkers and Next Generation Sequencing in Chronic Kidney Disease

Authors

  • Ying Shi, MD
  • Hao Yi, MD
  • Chunling Huang, PhD
  • Carol A. Pollock, MD
  • Xin-Ming Chen, PhD

Keywords:

personalized, therapeutic, sequencing

Abstract

Biomarkers are valuable for early diagnosis, predicting prognosis and monitoring therapeutic
efficacy in medicine, and particularly important in ‘personalized medicine’.1 Next generation
sequencing technologies and their application in human diseases to foster human healthcare
and personalized medicine have been recognized.2
To date, reliable biomarkers for chronic kidney disease (CKD) are not available in clinic and the application of next generation sequencing
technologies in CKD has not been well studied.

Downloads

Published

2016-08-10

How to Cite

Ying Shi, MD, Hao Yi, MD, Chunling Huang, PhD, Carol A. Pollock, MD, & Xin-Ming Chen, PhD. (2016). Biomarkers and Next Generation Sequencing in Chronic Kidney Disease. Nephrology, 23–25. Retrieved from https://openventio.us/index.php/NOJ/article/view/2298

Issue

Volume 2 Issue 1 2016

Section

Articles

License

All content published in Nephrology – Open Journal (NOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.